DeepMed Research

UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

Sickle Cell, Pain and Mediterranean Diet

Not Applicable

Not yet recruiting

Conditions: Sickle Cell
Mediterranean Diet
Sickle Cell Disease
Sickle Cell Disease Without Crisis

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 30

Registration Number: NCT06886477

Site-randomized Trial of an Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

Not Applicable

Not yet recruiting

Conditions: Undiagnosed HIV Infection
Populations That Are Reluctant to Test for HIV
Long-term Undiagnosed HIV Infection
Individuals With Newly-diagnosed HIV Infection
HIV-related Stigma
Access to HIV Testing

First Posted Date: 2025-03-04

Last Posted Date: 2025-03-04

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 2480

Registration Number: NCT06857071

Locations: 🇿🇦
Centre for Community-based Research, Human Sciences Research Council, Pietermaritzburg, KwaZulu-Natal, South Africa

Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions

Not Applicable

Not yet recruiting

Conditions: Opioid Overdose Prevention
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Reduction of Substance Use-related Stigma
Non-substance-using People With a Friend or Family Member Who Uses Opioids
Peer Harm Reduction Support Champions

First Posted Date: 2025-02-12

Last Posted Date: 2025-02-12

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 600

Registration Number: NCT06823453

Locations: 🇺🇸
Community Outreach Intervention Projects (COIP), Chicago, Illinois, United States

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients with High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia, Relapsed, Adult
Acute Myeloid Leukemia Refractory
Chronic Myeloid Leukemia - Accelerated Phase
Myelodysplastic Syndromes

Interventions: Radiation: Intensity modulated total marrow irradiation
Drug: Cyclophosphamide (CTX)
Drug: Fludarabine (Fludara)
Drug: Busulfan (conditioning for ALLO Transplant)

First Posted Date: 2025-01-31

Last Posted Date: 2025-02-04

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 38

Registration Number: NCT06802315

Locations: 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States

Research Investigating Drug Effects-2 (RiDE-2)

Early Phase 1

Not yet recruiting

Conditions: Cannabis Use
Healthy
Substance Use Disorder (SUD)

Interventions: Drug: Placebo Oral Capsule
Drug: THC

First Posted Date: 2025-01-06

Last Posted Date: 2025-01-06

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 144

Registration Number: NCT06758596

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

An Intervention to Reduce Sedentary Behavior for Black Adults With Chronic Kidney Disease

Not Applicable

Recruiting

Conditions: Chronic Kidney Disease(CKD)

First Posted Date: 2024-12-31

Last Posted Date: 2025-05-01

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 40

Registration Number: NCT06754280

Locations: 🇺🇸
UI Health/University of Illinois Chicago, Chicago, Illinois, United States

Pilot Sleep Extension and Mood

Not Applicable

Recruiting

Conditions: Internalizing Mental Health Symptoms
Sleep Problems

First Posted Date: 2024-11-05

Last Posted Date: 2025-03-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 25

Registration Number: NCT06675799

Locations: 🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States

Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

Not Applicable

Recruiting

Conditions: Obesity
Depression

Interventions: Behavioral: vCare Intervention (6-month active treatment followed by 6-month maintenance)
Behavioral: vCare Intervention (active treatment after 6 months)

First Posted Date: 2024-10-10

Last Posted Date: 2025-02-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 440

Registration Number: NCT06636058

Locations: 🇺🇸
Department of Medicine, Vitoux Program on Aging and Prevention, Chicago, Illinois, United States
🇺🇸
Washington University School of Medicine in St Louis, Saint Louis, Missouri, United States

Circadian Mechanisms, Glucose, and CV Risks in T1D

Not Applicable

Recruiting

Conditions: Type 1 Diabetes (T1D)

Interventions: Behavioral: Sleep stability intervention

First Posted Date: 2024-10-02

Last Posted Date: 2025-04-15

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 80

Registration Number: NCT06624046

Locations: 🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States

Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease

Not Applicable

Not yet recruiting

Conditions: Parkinson Disease (PD)

Interventions: Behavioral: GET Up PD
Behavioral: Stretching and Flexibility

First Posted Date: 2024-09-19

Last Posted Date: 2025-02-28

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 50

Registration Number: NCT06603012

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy